OCT 31, 2018 11:02 AM PDT

Masking the Pathogen

WRITTEN BY: Nicholas Breehl

Pathogens constantly threaten organisms of all sorts that they encounter. Luckily, for most organisms, their immune system is set up to destroy the pathogen, thereby removing the danger. Immune systems, over time, have evolved many characteristics that will allow them to be better equipped to ward off the pathogen. Unfortunately, the pathogens are also continuously changing in such a way to increase their odds at survival.

A recent study shows that some bacterial pathogens, like those known to cause strep throat, pneumonia, rheumatic fever or other diseases, can create the components necessary for DNA replication using a ribonucleotide reductase enzyme that does not require a metal ion cofactor. In most DNA replication processes, these metal ions are required. One way the immune system has evolved to mitigate this metal-ion-required replication is by way of sequestering the iron and manganese ions causing a lag in pathogen replication.

The study is published in the scientific journal known as Proceedings of the National Academy of Science and describes a novel subclass of metal-free ribonucleotide reductase enzymes used by these bacteria. The information revealed in this study might help scientists to develop better antibiotics.

"Every organism uses ribonucleotide reductase (RNR) enzymes to make the nucleotide building blocks needed for DNA replication and repair," said Amie Boal, assistant professor of chemistry and biochemistry and molecular biology at Penn State and the lead author of the paper. "Because RNRs are essential, they are validated drug targets for some cancers and viral infections, but they have not yet been exploited as drug targets in pathogenic bacteria. One of the goals of our work is to better understand the cofactors required by RNRs to function, which will hopefully inspire the creation of new, potent antimicrobial drugs that can inhibit the enzyme."

Ribonucleotide reductase enzymes carry out intricate chemical reactions to convert ribonucleotides into deoxyribonucleotides. Ribonucleotides are the building blocks of RNA present in the cell while deoxyribonucleotides are the building blocks of DNA. All known RNRs used during aerobic metabolism require a metal ion cofactor, which acts as a powerful oxidizing agent to drive the conversion.

The team of researchers provides insight into a subclass of RNR that is capable of performing the ribonucleotide conversion to deoxyribonucleotides without the aid of a metal ion in the bacterial pathogens.

"Requiring a trace-metal cofactor is the Achilles heel of an RNR, especially in pathogenic bacteria," said Gavin Palowitch, a Ph.D. candidate in biochemistry, microbiology, and molecular biology at Penn State and co-author of the study. "When a pathogen invades your body, one of the things that your immune system can do is try to deprive it of iron and manganese ions in an attempt to slow reproduction. If you have a way to make DNA that doesn't rely as much on a metal cofactor, that's a novel tactic for evading the immune response."

The subclass of RNR studied at Penn State can make use of modified amino acids in place of the metal ion as the oxidizing agent driving the composition of DNA nucleotides. The study shows that modification requires a separate protein to begin the process. However, the study did not investigate if a metal is necessary for the synthesis of the modified amino acid and then lost at a later time.

The researchers share that, “The need for another activating protein is critical for thinking about inhibiting this enzyme with antibiotic drugs.” It is known that protein-protein interaction is a valuable target location for small molecule therapeutic disruption.

 Sources: PNAS, PSU, Science Daily, YouTube

About the Author
You May Also Like
OCT 31, 2019
Cancer
OCT 31, 2019
Unpacking lactate's role in the Warburg effect
In a recent issue of Nature, the findings of one study made a particularly big splash: how and why cancer cells use energy differently than healthy cells. ...
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Antibiotic Usage May Cause Parkinson's, Study Finds
A study from Helsinki University Hospital, Finland suggests that excessive usage of certain antibiotics may increase one’s risk of developing Parkins...
JAN 14, 2020
Technology
JAN 14, 2020
Can Virtual Reality Influence an Increase in Vaccinations?
Can a virtual reality (VR) help increase flu vaccination rates? Apparently, yes! A recent study using VR stimulation is aiming to show how the flu spreads ...
MAR 29, 2020
Cell & Molecular Biology
MAR 29, 2020
Learning More About Boosting Immunity in Older Adults
Older adults are more susceptible to infections and don't generate a robust immune response after a vaccination....
Loading Comments...